The researchers identified two compounds capable of enhancing memory, reinstating glutamatergic and cholinergic functions, diminishing amyloid-1β and tau pathologies, and alleviating Alzheimer’s disease pathological characteristics in nematode and mouse models by a machine learning and cross-species screening methodology (Zeng et al., 2022). The gene discussed is MAPT; the disease is Alzheimer disease.